1) Bookman MA : GOG182─ICON5 ASCO 5─arm phaseIIIrandomized trial of paclitaxel(P)and carboplatin(C)vs combination with gemcitabine(G), PEG─lipososomal doxorubicin(D), or topotecan(T)in patients with advanced stage epithelial ovarian cancer or peritoneal carcinoma ASCO proceeding#5002, 2006
2) Tew WP, Colombo N, Ray I, et al : VEGF─Trap for patients with recuurent platinum─resistant epithelial ovarian cancer. ASCO proceeding #5508, 2007
3) Campos SM, Dizon DS, Cannistra M, et al : Safety of maintenance bevacizumab after first─line chemotherapy for ovarian and mullerian cancers. ASCO proceeding #5517, 2007
4) Herzog TJ, Spirtos NM, Hines JF, et al : Preliminary safety and efficacy results of phaseIIstudy of oxaliplatin, docetaxel, and bevacizumab as first─line chemotherapy of advanced cancer of the ovary, peritoneum, and fallopian tube. ASCO proceeding #5518, 2007
5) Winter WE 3rd, Maxwell GL, Tian C, et al : Prognostic factors for stageIIIepithelial ovarian cancer : a Gynecologic Oncology Group Study. J Clin Oncol 25 : 3621─3627, 2007
6) Itamochi H, Kigawa J, Sugiyama T, et al : Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol 100 : 281─287, 2002
7) Randall ME, Filiaci VL, Muss H, et al : Randomized phaseIIItrial of whole─abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma : a Gynecologic Oncology Group Study. J Clin Oncol 24 : 36─44, 2006
8) Susumu N, Sagae S, Udagawa Y, et al : Randomized phaseIIItrial of pelvic radiotherapy versus cisplatin─based combined chemotherapy in patients with intermediate─and high─risk endometrial cancer : A Japanese Gynecologic Oncology Group study. Gynecol Oncol 108 : 226─233, 2007
9) Kanamori Y, Kigawa J, Itamochi H, et al : Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res 7 : 892─895, 2001
10) Clinical practice guideline in oncology cervical cancer. V1 National comprephensive cancer network, 2006
11) Neoadjuvent chemotherapy for cervical cancer mata─analysis collaboration : Neoadjuvent chemotherapy for locally advanced cervical cancer. Eur J Cancer 39 : 2470─2486, 2003
12) Katsumata N, Yoshikawa H, Hirakawa T, et al : PhaseIII randomized trial of neoadjuvant chemotherapy for followed by radical hysterectomy versus RH for bulky stageI/II cervical cancer. ASCO proceeding #5013, 2006
13) Green JA, Kirwan JM, Tierney JF, et al : Survival and recurrence after concominant chemotherapy and radiotherapy for cancer of the uterine cervix : a systematic review and meta─analysis. Lancet 358 : 781─786, 2001
14) Rose PG, Bundy BN, Watkins EB, et al : Concurrent cisplatin─based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 : 1144─1153, 1999
15) Koutsky LA, Ault KA, Wheeler CM, et al : A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347 : 1645─1651, 2002
16) Naniwa J, Kigawa J, Kanamori Y, et al : Genetic diagnosis for chemosensitivity with drug─resistance genes in epithelial ovarian cancer. Int J Gynecol Cancer 17 : 76─82, 2007